WHITE HOUSE STRATEGY — Monday offered a glimmer of insight into the Biden administration’s strategy following Friday night’s ruling that put the abortion pill mifepristone — the most common method for ending a pregnancy — in jeopardy. The Department of Justice’s 49-page emergency motion, which asked the 5th U.S. Circuit Court of Appeals to keep the ruling on hold, argued that U.S. District Court Judge Matthew Kacsmaryk defied precedent when he said the plaintiffs — doctors and organizations representing them — had standing because they might one day treat patients suffering from side effects caused by the pills. Perhaps in a nod to the conservative-leaning judges on the 5th Circuit, the government wondered about the slippery slope that could follow should this reasoning stand. “An association of doctors could, for example, challenge the licensing of federal firearms dealers, or allegedly inadequate highway safety standards, on the theory that some individuals may be injured and seek treatment from the association’s members,” the government wrote. The 5th Circuit gave the anti-abortion groups that brought the lawsuit against the FDA until midnight Central time on Tuesday to respond. … The DOJ also asked a federal judge in Washington state to “clarify” his own Friday night order directing the FDA to maintain access to the pills in much of the country. The two orders seem to be “in significant tension,” a conflict that could make this case ripe for the Supreme Court should the government get no relief from the 5th Circuit. One strategy the Biden administration won’t pursue? Ignoring the court order, suggested by several Democrats and at least one Republican. “You know, as a dangerous precedent is set for the court to set aside the FDA’s and expert judgment regarding a drug’s safety and efficiency, it will also set a dangerous precedent for this administration to disregard a binding decision,” White House press secretary Karine Jean-Pierre said at her briefing Monday. States stock up: Democratic governors aren’t counting on the courts to bail them out, POLITICO’s Rachel Bluth reports. Gov. Gavin Newsom said Monday that California had secured 250,000 of another abortion pill, misoprostol, and negotiated the purchase of up to 2 million more. California shared the terms of the purchase agreement with other Democratic-led states that might be interested in making a similar buy. Massachusetts Gov. Maura Healey also announced Monday that her state would purchase 15,000 doses of mifepristone through the state university system. Last week, Washington Gov. Jay Inslee announced his state had purchased 30,000 doses of mifepristone through the correctional system and 10,000 doses through the university system. WELCOME TO TUESDAY PULSE. Hospitals have been particularly crowded in recent years — not just with humans. A moose entered an Alaskan hospital recently, looking for a snack (enter: the plant in the lobby). Had a moose sighting recently? What about a sighting of the next big piece of health legislation? Let us know at dpayne@politico.com and kmahr@politico.com. TODAY ON OUR PULSE CHECK PODCAST, host Ben Leonard talks with Alice Miranda Ollstein, who unpacks the legal turmoil following differing federal court decisions on the abortion pill mifepristone.
|
No comments:
Post a Comment